Navigation Links
Elsevier / Gold Standard's Kay Morgan Awarded NCPCP Highest Honor
Date:5/17/2012

TAMPA, Florida, May 17, 2012 /PRNewswire/ --

Morgan honored with The TIME Award for lifetime contributions to NCPDP

The National Council for Prescription Drug Programs (NCPDP), a not-for-profit standards organization with more than 1,500 members throughout the pharmacy services industry, awarded Kay Morgan, Senior Vice President of Drug Products and Industry Standards Research and Compliance for Elsevier / Gold Standard, with its highest honor, The TIME Award, last week at its annual conference in Phoenix. Elsevier / Gold Standard is a leading drug information and drug decision support provider.

NCPDP established The TIME (The Individual Member Excellence) Award in 1990. It honors an NCPDP member for unselfish devotion toward meeting the goals and objectives of the organization. For the past 35 years, NCPDP has brought together all parts of the industry - payers, providers and suppliers - to develop business solutions and guidance for promoting information exchanges related to medications, supplies, and services within the healthcare system, to improve safety, privacy and healthcare outcomes for patients, while reducing costs in the system.

The NCPDP Conference Daily quoted from Kay's TIME nomination: "Kay is consistently and energetically involved in the activities of NCPDP and is an available resource for members to understand, influence and comply with the standards represented by the Council. This membership segment has brought new perspectives to the organization as we continue to address industry challenges. Kay has also represented pharmacy and NCPDP concerns in her interactions with the FDA and others as the groups work together toward industry solutions."

Elsevier/Gold Standard

Based in Tampa, FL, Elsevier/Gold Standard uses innovative technologies to provide a complete suite of drug information and decision support soluti
'/>"/>

SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elsevier Launches Second Annual Mosbys Superheroes of Nursing Contest During Nurses Week 2012
2. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
3. Elsevier Appoints New President of Elsevier CPM Resource Center
4. Elsevier Launches New Journal: Journal of Applied Research in Memory and Cognition
5. Elsevier Launches New Journal: Journal of Obsessive-Compulsive and Related Disorders
6. Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE
7. Elsevier Introduces Expert Discovery Application for SciVerse Hub
8. Elsevier Honored With Six PROSE Awards
9. Elsevier and OpenHelix Release Tutorial Suites for SciVerse Applications
10. Elsevier and Leidens Scaliger Institute Establish Fellowship Program for Rare Books Scholars
11. Elsevier Announces Two Tetrahedron Symposia for 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... PALO ALTO, Calif. , Aug. 1, 2014 ... today announced a partnership to expand awareness of proper ... the CFChef Shares program. CFChef Shares will run from ... AbbVie,s CFChef program – an online resource for CF ... a healthy diet by submitting recipes to the ...
(Date:8/1/2014)... Mass. , Aug. 1, 2014  NxStage Medical, Inc. ... dialysis products, today announced that Jeffrey H. Burbank , ... Officer, will present at the 34 th Annual Canaccord ... Boston, MA , on Wednesday, August 13 th ... will be made available at http://ir.nxstage.com/ .  ...
(Date:8/1/2014)... Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced ... report its second quarter 2014 financial results on Monday, ... J. Joseph Kim and CFO Peter ... corporate update, and participate in a live Q&A with ... VGX-3100, Inovio,s immune therapy targeting pre-cancers and cancers associated ...
Breaking Medicine Technology:AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3
(Date:8/1/2014)... The European gas chromatography systems report defines and segments the ... The gas chromatography systems market in Europe is valued at ... around $247.6 million by 2018, at a CAGR of 5.3% ... the European gas chromatography systems market, to get an idea ... of the segmentation of gas chromatography systems market in the ...
(Date:8/1/2014)... 2014 The North America Sports Drink Market ... America, with analysis and forecast of revenue. The Sports Drink ... $5,021.9 million in 2012 to $6,243 million by 2018, at ... through the TOC of the North America Sports Drink market ... This also provides a glimpse of the segmentation in the ...
(Date:8/1/2014)... Gerontological Society of America (GSA) the ... aging has chosen Carole B. Lewis, PT, DPT, ... recipient of the Excellence in Rehabilitation of Aging Persons ... acknowledge outstanding contributions in the field of rehabilitation. The ... or patient care, or publications that may include scholarly ...
(Date:8/1/2014)... Home Care Assistance of Cincinnati , ... to be recognized as a 2014 Best of Home Care ... care providers who rank in the top 50th percentile in ... interviews conducted by Home Care Pulse. , “The Best ... the best of the best!” says Home Care Pulse Founder ...
(Date:8/1/2014)... 01, 2014 With fast food restaurants on ... convenience of processed, microwavable dinners, it is no wonder that ... offer patients a mere quick fix for shedding this dangerous ... part of the country, get slimmer and healthier for the ... the tools and education on how to avoid obesity ...
Breaking Medicine News(10 mins):Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Lewis to receive GSA's 2014 Excellence in Rehabilitation of Aging Persons Award 2Health News:Cincinnati Senior Care Company Receives 2014 Best of Home Care® Employer of Choice Award 2Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 2Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 3
... cancer that is being developed is the use of ... normal cells unharmed. These viruses are known as virotherapeutics. ... Jennerex Biotherapeutics, San Francisco, have described the development of ... and rabbits. , After selecting a highly potent strain ...
... in cancer incidence and mortality are well documented. ... is a factor in cancer disparities, other factors ... genetics, hormonal status, lifestyle and behavior, screening policies, ... response to therapy, and post-therapeutic surveillance. , ...
... used to cut down on bleeding during cardiac surgery , , ... Drug Administration on Thursday said it will review the safety ... trial was stopped early due to an increase in deaths ... first approved by the FDA in 1993, is typically used ...
... Oct. 25 /PRNewswire-FirstCall/ - SXC Health Solutions Inc.,(NASDAQ: ... Glenn, Chairman and,Chief Executive Officer, will host a conference ... to discuss the Company,s fiscal 2007 third quarter,financial results. ... at 6:00 a.m. ET that same day. All ...
... During the Second Fiscal ... Quarter ... Reiterates Fiscal 2008 Guidance, MOUNTAIN VIEW, Calif., Oct. 25 Pharsight,Corporation (OTC ... clinical drug development, today,announced financial results for its second quarter of fiscal 2008, ...
... with Osiris on a Phase II Trial to Evaluate ... , New York, NY October 25, ... a partnership with Osiris Therapeutics, Inc. (NASDAQ:OSIR) to support ... cell therapy product, to preserve and regenerate insulin-producing cells ...
Cached Medicine News:Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 3Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 4Health News:SXC Health Solutions to Host Fiscal 2007 Third Quarter Financial Results Conference Call 2Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 2Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 3Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 4Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 5Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 6Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 7Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 8Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 9Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 10Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 11Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 12Health News:JDRF Partners with Osiris to evaluate an immunomodulatory cell therapy product for type 1 diabetes 2
... Complete includes the nutrients used in the ... Antioxidant Supplement Trial (LAST), which suggested no ... in a one year period. Macula Complete ... in peer-reviewed studies to support the mitochondria, ...
... Soft Gel Lutein patented formula is based ... PreserVision® AREDS formula, with the beta-carotene substituted ... is a carotenoid found in dark leafy ... highly concentrated in the macula, the part ...
... & Lomb PreserVision® AREDS formula is the ... supplement clinically proven effective in the 10-year ... Eye Disease Study (AREDS). , PreserVision® AREDS ... supplement with the antioxidant vitamins A, C, ...
... scientific formulation that provides the foundation ... basic eye-specific nutritional support. All ingredients ... standards, when applicable. ScienceBased Health formulations ... maximum bioavailability, and are free of ...
Medicine Products: